Patients who achieved CR to glofitamab also showed a trend toward a higher percentage of CD8+ T-cell infiltration in the TME [ 49 , 51 ].
← all excerpts
The Role of the Tumor Microenvironment in T-Cell Redirecting Therapies of Large B-Cell Lymphoma: Lessons Learned from CAR-T to Bispecific Antibodies.
1
—
—